Clinical Trial Update: A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and feasibility of combining the mTOR inhibitor everolimus with cisplatin and radiotherapy for locally advanced cervical c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Afinitor (everolimus)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Locally Advanced Cervical Cancer | Phase 1 | Status: COMPLETED